75N91021C00003 Justification and Approval - redacted.pdf

This redacted justification document extends a sole source contract awarded by the National Cancer Institute to an unknown vendor for CyTOF and O-Link assessment services in support of the NCI COVID-19 in Cancer Patients Study. The justification modifies the period of performance by 12 months. It was signed on December 20, 2022. The services required under the contract include CyTOF and O-Link assessment to analyze immune responses and protein biomarkers in cancer patients infected with COVID-19. The National Cancer Institute within the National Institutes of Health and Department of Health and Human Services is the awarding agency.